Condition

Blood Transfusion Complication

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 3 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting1

Common interventions2

Lead sponsors shown3

Clinical trials

3 shown

The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal MetastasisNCT06244264 · 2024-03-15

RECRUITING

Investigation of the Relationship Between Blood Transfusion Volume and Development of Renal Failure in Pediatric Patients Undergoing Cardiovascular SurgeryNCT06889272 · 2024-01-31

COMPLETED

Anticoagulant/Antiaggregant Use and Postoperative Bleeding Risk in Patients With Bladder Tumor and Benign Prostatic HyperplasiaNCT05314582 · 2022-03-10

COMPLETED

Common interventions

Autoblood transfusionPROCEDURE1 blood transfusionOTHER1

Leading sponsors

Bezmialem Vakif University 1 Guangdong Provincial People's Hospital 1 Hacettepe University 1

Trial status mix

COMPLETED2

RECRUITING1

Phase mix

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.